
GlakoLens
Founded Year
2017Stage
Incubator/Accelerator | AliveTotal Raised
$1MAbout GlakoLens
GlakoLens is a medical devices company developing biosensors based on proprietary technology, first of which is a wearable, continuous (24h) intra-ocular pressure (IOP) monitoring device for the (early) diagnosis and personalized management of ocular hypertension and management of glaucoma. GlakoLens’ product, GlakoSense Platform, is based on non-invasive biosensor technology that will enable continuous IOP monitoring for 24 hours. It is a complete monitoring system including sensor-incorporated contact lenses, readout/recording units, and data analytics service. Specifically, the product is comprised of an electrically passive sensor embedded in a comfortable disposable soft contact lens, and a wearable electronic system to take non-contact measurements from the sensor and to store the data. The placement of the disposable contact lens sensor and the wearable electronic system are carried out by trained medical staff in the clinic. The patient wears the products for 24 hours and returns to the clinic the next day, where the staff downloads the IOP fluctuation data from the device and deliver the results to the ophthalmologists for evaluation. GlakoSense Platform will enable the streamlined collection of previously unobtainable IOP fluctuation data that is also precious for scientific research. Additionally, it will become a valuable tool for the development of ocular hypertension drugs and associated clinical research.
GlakoLens's Products & Differentiators
GlakoSense Platform
It is a smart contact lens system comprised of a sensor embedded contact lens, a readout antenna placed around the eye, a (Holter-like) readout unit carried in a pouch worn around the neck, a cable connecting the antenna and the readout unit, and a computer software for visualising and reporting the patient and monitoring data.
GlakoLens Patents
GlakoLens has filed 1 patent.
The 3 most popular patent topics include:
- Cardiac surgery
- Contact lenses
- Implants (medicine)

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
8/23/2018 | Metamaterials, Contact lenses, Resonator guitarists, Cardiac surgery, Implants (medicine) | Application |
Application Date | 8/23/2018 |
---|---|
Grant Date | |
Title | |
Related Topics | Metamaterials, Contact lenses, Resonator guitarists, Cardiac surgery, Implants (medicine) |
Status | Application |
Latest GlakoLens News
May 25, 2017
ACT Venture Partners made the investment. The company will use the funds to focus on further refining, testing and then certifying the technology. Founded by the members of a research group at Boğaziçi University and led by Prof. Günhan Dündar, Dr. Arda Deniz Yalçınkaya and Dr. Hamdi Torun, Glakolens is advancing a novel non-invasive continuous intra-ocular pressure (IOP) diagnostics and monitoring device based on proprietary technology licensed from Boğaziçi University. The company’s strategy is to focus on introducing a product to address specific needs in ophthalmology where there is need for viable products. The IOP sensor developed by Glakolens is based on a novel non-invasive approach to very accurately diagnose and passively monitor fluctuations in IOP by measuring certain properties of the eye. The data is collected wirelessly over a period without going to the hospital and further processed using various protocols to offer insights. FinSMEs
GlakoLens Frequently Asked Questions (FAQ)
When was GlakoLens founded?
GlakoLens was founded in 2017.
Where is GlakoLens's headquarters?
GlakoLens's headquarters is located at Bogazici University Teknopark 306, Kuzey Campus, Istanbul.
What is GlakoLens's latest funding round?
GlakoLens's latest funding round is Incubator/Accelerator.
How much did GlakoLens raise?
GlakoLens raised a total of $1M.
Who are the investors of GlakoLens?
Investors of GlakoLens include BIO Startup Program and ACT Venture Partners.
What products does GlakoLens offer?
GlakoLens's products include GlakoSense Platform.